(Q28070118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26758290%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Andrew Chan

series ordinal

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26758290%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Manuel Comabella

series ordinal

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26758290%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

1 reference

January 2016

1 reference

1 January 2016

5 references

25 April 2019

30 June 2019

5 September 2019

7 November 2019

19 November 2019

7 references

25 April 2019

30 June 2019

5 September 2019

7 November 2019

19 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26758290%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

30

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26758290%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26758290%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

41-51

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26758290%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial

10 June 2020

copyright license

5 references

25 April 2019

30 June 2019

5 September 2019

7 November 2019

19 November 2019

on focus list of Wikimedia project

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s40263-015-0299-y

0 references

cites work

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4733135

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4733135

Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4733135

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4733135

Teriflunomide and its mechanism of action in multiple sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4733135

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4733135

Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4733135

Birth outcomes in women who have taken leflunomide during pregnancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4733135

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4733135

Transection of the oesophagus for bleeding oesophageal varices

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4733135

The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro

29 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0299-Y

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0299-Y

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0299-Y

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0299-Y

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0299-Y

The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4733135

The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells

27 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/26758290

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40263-015-0299-Y

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26758290%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26758290%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26758290%20AND%20SRC:MED&resulttype=core&format=json